S
Michael Burke
Chief Commercial Officer, Ovation
SPECIALIZES IN: "Creative solutions" to product strategy
ROLE MODELS: "Can do good and do well at the same time"
Doing deals is fun," says Michael Burke, who's helped build Ovation from "a couple people in a room to 350 employees, 20 products, and four development programs." Executing CEO Jeff Aronin's strategy of acquiring and relaunching Big Pharma drugs in underserved market segments, Burke has become expert in prudent risk—the industry's holy grail.
Michael Burke
Training in what he calls creative solutions primed him for setting the commercial agenda at Ovation, where innovation barely describes the new forms of life he and Aronin have discovered in acquiring, partnering, and marketing their Big Pharma ugly ducklings. Burke has had the most fun with Sabril, which prior to Ovation sat at FDA "with an open Approvable Letter longer than any other product in history." But by collaborating with academics and advocates, Ovation filed a new NDA for infantile spasms, a condition with high unmet need.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.